NCT05504291 2026-02-17
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Children's Oncology Group
Phase 2 Recruiting
Clinical Trials
27 trialsNCT02870907 2026-01-07
RB SFCE 09
Institut Curie
Phase 2 Active not recruiting
NCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT02866136 2025-11-24
RETINO2011
Institut Curie
Phase 2 Active not recruiting
NCT00186888 2025-09-04
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
Phase 3 Completed
NCT05279300 2025-08-11
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
CStone Pharmaceuticals
Phase 1 Recruiting
NCT06760117 2025-01-06
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
Sun Yat-sen University
Phase 1 Recruiting
NCT06710821 2024-11-29
Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors
Sun Yat-sen University
Phase 1 Not yet recruiting
NCT05620862 2024-07-09
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors
Sun Yat-sen University
Phase 1 Active not recruiting
NCT00110110 2024-04-17
Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
The Hospital for Sick Children
Phase 2 Active not recruiting
NCT01783535 2024-04-16
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT01906814 2024-04-09
Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation
Sun Yat-sen University
Phase 3 Active not recruiting
NCT00993044 2023-10-06
VIT-B
Children's Hospital Los Angeles
Phase 1 Completed
NCT05080010 2021-10-15
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting
NCT00786669 2021-02-10
VITAC
Children's Hospital Medical Center, Cincinnati
Phase 1 Completed
NCT02116959 2020-04-16
Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
University of California, San Francisco
Phase 1 Terminated
NCT00186979 2017-04-26
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00980551 2017-03-03
RELRB1
Children's Hospital Medical Center, Cincinnati
Phase NA Withdrawn
NCT00003273 2015-12-03
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NYU Langone Health
Phase 2 Withdrawn
NCT02319486 2015-03-30
CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma
Sun Yat-sen University
Phase 4 Completed
NCT02137928 2014-12-19
Carboplatin Periocular Injection for Retinoblastoma
Sun Yat-sen University
Phase 3 Unknown
NCT01899066 2014-05-13
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Sun Yat-sen University
Phase 2 Unknown
NCT00006095 2014-02-21
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Children's Oncology Group
Phase 1 Completed
NCT00360750 2013-09-17
Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye
National Cancer Institute (NCI)
Phase NA Unknown
NCT00075699 2013-08-07
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002675 2013-06-28
Chemotherapy in Treating Patients With Retinoblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00002794 2011-10-04
Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Completed